JW (Cayman) Therapeutics Co Ltd Sustainability Reports
JW (Cayman) Therapeutics Co. Ltd. is a clinical-stage cell therapy company focused on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies. Its primary products include cellular immunotherapy treatments for oncology and autoimmune diseases within China.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 9845004E84F2D2AB6E81
FIGI: BBG00XXS5DL2
13 reports from 2020 to 2025
